Identification of a histidine-tyrosine cross-link in the active site of the cbb3-type cytochrome c oxidase from Rhodobacter sphaeroides

  1. Virve Rauhamäki*,,
  2. Marc Baumann,
  3. Rabah Soliymani,
  4. Anne Puustinen*,§, and
  5. Mårten Wikström*
  1. *Helsinki Bioenergetics Group, Program for Structural Biology and Biophysics, Institute of Biotechnology, University of Helsinki, P.O. Box 65, Viikinkaari 1, 00014, Helsinki, Finland; and
  2. Protein Chemistry Unit, Institute of Biomedicine, Biomedicum, University of Helsinki, 00014, Helsinki, Finland
  1. Edited by Harry B. Gray, California Institute of Technology, Pasadena, CA, and approved September 11, 2006 (received for review July 23, 2006)

Abstract

The heme-copper oxidases constitute a superfamily of terminal dioxygen-reducing enzymes located in the inner mitochondrial or in the bacterial cell membrane. The presence of a mechanistically important covalent bond between a histidine ligand of the copper ion (CuB) in the active site and a generally conserved tyrosine residue nearby has been shown to exist in the canonical cytochrome c oxidases. However, according to sequence alignment studies, this critical tyrosine is missing from the subfamily of cbb3-type oxidases found in certain bacteria. Recently, homology modeling has suggested that a tyrosine residue located in a different helix might fulfill this role in these enzymes. Here, we show directly by methods of protein chemistry and mass spectrometry that there is indeed a covalent link between this tyrosine and the copper-ligating histidine. The identity of the cross-linked tyrosine was determined by showing that the cross-link is not formed when this residue is replaced by phenylalanine, even though structural integrity is maintained. These results suggest a universal functional importance of the histidine-tyrosine cross-link in the mechanism of O2 reduction by all heme-copper oxidases.

Footnotes

  • To whom correspondence should be addressed. E-mail: virve.rauhamaki{at}helsinki.fi
  • Author contributions: V.R. and M.B. designed research; V.R., R.S., and A.P. performed research; V.R. analyzed data; and V.R. and M.W. wrote the paper.

  • §Present address: Finnish Institute of Occupational Health, Topeliuksenkatu 41, 00250, Helsinki, Finland.

  • The authors declare no conflict of interest.

  • This article is a PNAS direct submission.

  • Abbreviation:
    DM,
    n-dodecyl β-d-maltoside.
« Previous | Next Article »Table of Contents